News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Sharemaestro News Company research
Agilent Technologies added 1.8% for the week and is up 29.4% over 12 weeks, but the move is now 15.6% above Sharemaestro Fair Value on only 0.6x average volume.
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Montag A & Associates Inc. significantly increased its stake in Agilent Technologies, Inc. (NYSE:A) by 911.5% in the second quarter, acquiring an additional 11,850 shares, bringing their total holdings to 13,150 shares valued at $1,750,000. Other institutional investors also adjusted their positions in the …
KBC Group NV increased its stake in Agilent Technologies, Inc. (NYSE:A) by 18.4% in the second quarter, bringing its total holdings to 81,883 shares valued at $10.88 million. Several other institutional investors also adjusted their positions in Agilent, while analysts have given the stock …
LFG Wealth Partners LLC recently invested $1.75 million in Agilent Technologies, Inc., acquiring 13,176 shares during the second quarter. Other institutional investors also increased their stakes in the company, which reported strong quarterly earnings and maintained its fiscal 2026 EPS guidance. Analyst sentiment for …
VCI Wealth Management LLC increased its stake in Agilent Technologies (NYSE:A) by 70.5% in the second quarter, acquiring an additional 9,105 shares, bringing its total holdings to 22,020 shares valued at $2.93 million. Agilent reported strong quarterly earnings, exceeding analyst estimates with an EPS …
111 Capital has acquired a new stake of 9,431 shares in Agilent Technologies, Inc. (NYSE:A) during the second quarter, valued at approximately $1.253 million. This comes as several other institutional investors also increased their holdings in the medical research company. Agilent Technologies recently reported …
Principal Financial Group Inc. reduced its stake in Agilent Technologies, Inc. by 5.4%, selling 18,893 shares and retaining 332,822 shares valued at approximately $44.2 million. Other institutional investors also adjusted their positions in Agilent, which reported strong quarterly earnings and year-over-year revenue growth. The …
TD Asset Management Inc. reduced its stake in Agilent Technologies (NYSE:A) by 2.6% in the second quarter, selling 26,544 shares but still holding 996,884 shares valued at $132.4 million. Despite this reduction, institutional investors collectively own a significant 87.41% of the company. Analysts maintain …
Qsemble Capital Management LP significantly reduced its stake in Agilent Technologies (NYSE:A) by 77.4% in the second quarter, selling 80,925 shares and retaining 23,610 shares valued at approximately $3.14 million. Despite this reduction, Agilent Technologies reported strong quarterly earnings of $1.49 per share, surpassing …
Massachusetts Financial Services Co. significantly reduced its stake in Agilent Technologies, selling 2.61 million shares, though still retaining 10.01 million shares valued at approximately $1.36 billion. Despite this sale, analysts generally maintain a "Moderate Buy" rating for Agilent, with a consensus price target of …
Oppenheimer Asset Management Inc. significantly increased its stake in Agilent Technologies (NYSE:A) by 75.9% in the second quarter, adding 41,794 shares and bringing its total holding to $12.9 million. This move is part of a broader trend where institutional investors and hedge funds own …
Jennison Associates LLC significantly increased its stake in Agilent Technologies (NYSE:A) by 81.3% in the second quarter, now owning 621,278 shares valued at $82.5 million. This comes as Agilent reported strong quarterly earnings, beating estimates with an EPS of $1.49 and a 10% revenue …
Vontobel Holding Ltd. decreased its stake in Agilent Technologies, Inc. (NYSE:A) by 18.7% in the second quarter, selling 8,489 shares and holding a total of 36,863 shares valued at $4.897 million. Several other institutional investors also adjusted their positions in Agilent, which currently holds …
NewEdge Advisors LLC significantly reduced its stake in Agilent Technologies, selling 10,106 shares, though institutional interest in the company remains strong with several firms increasing their holdings. Analysts maintain a "Moderate Buy" rating for Agilent, which recently surpassed earnings and revenue expectations with 10% …
Assenagon Asset Management S.A. significantly reduced its stake in Agilent Technologies (NYSE:A) by 75.3% in the second quarter, selling 31,934 shares. Despite this, other institutional investors like State Street Corp, Geode Capital Management LLC, and Morgan Stanley increased their holdings. Agilent Technologies reported strong …
Eurizon SLJ Capital Ltd has invested $10.13 million in Agilent Technologies, acquiring 76,249 shares, making it their ninth-largest holding. Agilent Technologies reported strong quarterly earnings, surpassing analyst expectations with $1.49 EPS and $1.83 billion in revenue, and provided positive fiscal year 2026 guidance. The …
Agilent Technologies (A) stock shows a mixed valuation, with its Discounted Cash Flow (DCF) model suggesting it is undervalued by 16.8%, indicating potential upside. However, its P/E ratio of 29.7x, while below the industry average, is above its modeled fair P/E of 24.1x, suggesting …
Agilon Health Inc (AGL) saw its stock rise by 9.0% to $96.90, but GuruFocus's GF Value indicates the stock is overvalued by 6.2% compared to its intrinsic value of $91.24. Despite a strong GF Score of 71/100, driven by good growth and valuation ranks, …
J. L. Bainbridge & Co. Inc. recently acquired a new stake in Agilent Technologies (NYSE:A), purchasing 27,150 shares valued at approximately $3.6 million, making it their 27th largest position. Agilent Technologies reported strong quarterly earnings, beating analyst estimates with an EPS of $1.49 and …
Agilon health (AGL) reported a swing to profit in Q2 2026, with net income of US$17.96 million compared to a loss a year earlier, and raised its full-year 2026 revenue guidance. This improvement, driven by better medical cost management, suggests enhanced profitability without sole …
Over the last year, Agilent Technologies insiders have sold US$1.1m worth of stock, which could signal caution. While some insider buying occurred, the selling volume was higher. This activity might indicate that insiders believe the stock is fully valued or that future growth prospects …
Summitry LLC slightly reduced its stake in Agilent Technologies by 1.1% in Q2 but still holds 666,332 shares valued at $88.5 million, making it their 8th largest position. Agilent Technologies reported strong Q2 earnings, surpassing analyst expectations with $1.49 EPS and $1.83 billion in …
Louisbourg Investments Inc. reduced its stake in Agilent Technologies by 22.2% in the second quarter, selling 10,313 shares but still holding 36,056 shares valued at approximately $4.79 million. Despite this reduction, analysts generally maintain a "Moderate Buy" rating for Agilent, with an average price …
Agilent Technologies (A) stock is holding steady after reporting stronger-than-expected Q2 2026 earnings per share of $1.49 and 10% revenue growth to $1.83 billion. The company also issued fiscal 2026 EPS guidance between $6.00 and $6.10, which analysts anticipate will be around $6.01. A …
Oak Thistle LLC acquired 28,409 shares of Agilent Technologies (NYSE:A) in the second quarter, valued at approximately $3.77 million, with several other institutional investors also initiating positions. Analysts have a "Moderate Buy" consensus rating for Agilent with an average price target of $160.24, following …
Handelsbanken Fonder AB has increased its stake in Agilent Technologies (NYSE:A) by 34.4% during the second quarter, now owning 162,195 shares valued at $21.54 million. Other institutional investors also adjusted their positions in the medical research company. Agilent Technologies has received a "Moderate Buy" …
Gateway Investment Advisers LLC significantly reduced its stake in Agilent Technologies, Inc. (NYSE:A) by 82.9% in the second quarter, selling over 60,000 shares. Despite this, other institutional investors like Mitsubishi UFJ Asset Management Co. Ltd. and Mirae Asset Global Investments Co. Ltd. increased their …
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Senior Vice President, Investor Relations - Evan Smith Chief Executive Officer - Timothy O'Rourke Chief Financial Officer - Jeffrey Schwaneke Full Conference Call Transcript Operator: Hello, everyone. Thank …
Agilent Technologies Inc. announced that the FDA has approved the expanded use of its PD-L1 IHC 22C3 pharmDx for Dako Omnis platform. This approval allows for identifying patients with esophageal squamous cell carcinoma, triple-negative breast cancer, cervical cancer, and gastric or gastroesophageal junction adenocarcinoma …
The average 12-month price target for Agilent Technologies, Inc. (A) stock has been raised from $159.33 to $160.17 by 18 analysts, with forecasts ranging from $135 to $185 per share. This new target implies a potential upside of approximately 7% from the August 11 …
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Agilon Health (AGL) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the …
Search by ticker symbol or company name and select a result to open its chart.